Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease

British Journal of Haematology

Volumn 97, Issue 4, 1997, Pages 785-797

  Woodward, M ^a   Lowe, G D O ^b   Rumley, A ^b   Tunstall Pedoe, H ^c   Philippou, H ^d   Lane, D A ^d   Morrison, C E ^b  

^a UNIVERSITY OF READING   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Coagulation factors; Coagulation inhibitors; Thrombosis

Indexed keywords

ANTITHROMBIN; ASCORBIC ACID; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING INHIBITOR; FIBRINOGEN; PROTEIN C; PROTEIN S;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY RISK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIAL CLASS; THROMBOSIS;

EID: 0030761812     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.1232935.x     Document Type: Article

References (55)

1. Allaart, C.F. & Briët, L. (1994) Familial venous thrombophilia. Haemostasis and Thrombosis, 3rd edn (ed. by A. L. Bloom, C. D. Forbes, D. P. Thomas and E. G. D. Tuddenham), pp. 1349-1360. Churchill Livingstone, Edinburgh.
2. Bailleisen, L., Bailey, J., Epping, P.-H., Schulte, H. & van de Loo, J. (1985) Epidemiological study on factor VII, factor VIII and Fibrinogen in an industrial population. I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause. Thrombosis and Haemostasis, 54, 475-479.
3. Bauer, K.A., Broekmans, A.W., Bertina, R.M., Conard, J., Horellou, M.H., Samama, M.M. & Rosenberg, R.D. (1988) Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. Blood, 71, 1418-1426.
4. Bauer, K.A. & Rosenberg, R.D. (1994) Activation markers of coagulation. Bailliere's Clinical Haematology, 7, 523-540.
5. Bulpitt, C.J. (1995) Vitamin C and vascular disease. British Medical Journal, 310, 1548-1549.
6. Carvalho de Sousa, J., Bruckert, E., Giral, P., Soria, C., Chapman, J. & Truffert, J. (1989) Coagulation factor VII and plasma triglycerides: decreased catabolism as a possible measure of factor VII hyperactivity. Haemostasis, 19, 125-130.
7. Conlan, M.G., Folsom, A.R., Finch, A., Davis, C.E., Marcucci, G., Sorlie, P. & Wu, K.K. (1994) Antithrombin III: associations with age, race, sex and cardiovascular disease risk factors. Thrombosis and Haemostasis, 72, 551-556.
8. Conlan, M.G., Folsom, A.R., Finch, A., Davis, C.E., Sorlie, P., Marcucci, G. & Wu, K.K. (1993a) Associations of factor VIII and von Willebrand factor with age, race, sex and risk factors for atherosclerosis. Thrombosis and Haemostasis, 70, 380-385.
9. Conlan, M.C., Folsom, A.R., Finch, A., Davis, C.E., Sorlie, P. & Wu, K.K. (1993b) Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: the ARIC Study. Thrombosis and Haemostasis, 70, 762-767.
10. Constantino, M., Merskey, C., Kudzma, D.J. & Zucker, M.J.B. (1977) Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia-associated with cholesterol and triglyceride levels. Thrombosis and Haemostasis, 38, 465-474.
11. Elkeles, R.S. Chakrabarti, R., Vickers, M., Stirling, Y. & Meade, T.W. (1980) Effect of treatment of hyperlipidaemia on haemostatic variables. British Medical Journal, 281, 973-974.
12. Ernst, E. & Resch, K.L. (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Annals of Internal Medicine, 118, 956-963.
13. Folsom, A.R. (1995) Epidemiology of fibrinogen. European Heart Journal, 16, (Suppl. A), 21-24.
14. Folsom, A.K., Conlan, M.G., Davis, C.E. & Wu, K.K. (1992) Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Annals of Epidemiology, 2, 481-494.
15. Folsom, A.R., Wu, K.K., Davis, C.E., Conlan, M.G., Sorlie, P.D. & Szklo, M. (1991) Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis, 91, 191-205.
16. Fuller, J.H., Keen, H., Jarrett, R.J., Owen, T., Meade, T.W., Chakrabarti, R., North, W.R.S. & Stirling, Y. (1979) Haemostatic variables associated with diabetes and its complications. British Medical Journal, ii, 964-966.
17. Gale, C.R., Martyn, C.H., Winter, P.D. & Cooper, C. (1995) Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. British Medical Journal, 310, 1548-1549.
18. Heinrich, J., Balleisen, F., Schulte, H., Assmann, G. & van de Loo, J. (1994) Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM Study in healthy men. Arteriosclerosis and Thrombosis, 14, 54-59.
19. Hoffman, C.J., Lawson, W.E., Miller, R.H. & Hultin, M.B. (1994) Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arteriosclerosis and Thrombosis, 14, 1737-1740.
20. Hursting, M.J., Stead, A.G., Grout, F.V., Horvath, B.Z. & Moore, B.M. (1993) Effects of age, race, sex and smoking on prothrombin fragment 1 + 2 in a healthy propulation. Clinical Chemistry, 39, 683-687.
21. Khaw, K.-T. & Woodhouse, P. (1995) Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. British Medical Journal, 310, 1559-1563.
22. Kienast, J., Thompson, S.G., Raskino, C., Pelzer, H., Fechtrup, C., Ostermann, H. & van de Loo, J. (1993) Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris; relalion to the presence of severity of coronary atherosclerosis. Thrombosis and Haemostosis, 70, 550-553.
23. Lee, A.J., Fowkes, F.G.R., Rattray, A., Rumley, A. & Lowe, G.D.O. (1996) Haemostatic and Theological factors in intermittent claudication: the influence of smoking and extent of arterial disease. British Journal of Haematology, 92, 226-230.
24. Lee, A.J., Smith, W.C.S., Lowe, G.D.O. & Tunstall-Pedoe, H. (1990) Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. Journal of Clinical Epidemiology, 45, 913-919.
25. Leng, G.C. & Fowkes, F.G.R. (1992) The Edinburgh Claudication Questionnaire: an improved version of the WHO Rose questionnaire for use in epidemiologic surveys. Journal of Clinical Epidemiology, 45, 1101-1104.
26. Lowe, G.D.O., Fowkes, F.G.R., Dawes, J., Donnan, P.T., Lennie, S.E. & Housley, E. (1995) Blood viscosity, fibrinogen and activation of coagulation and leucocytes in peripheral arterial disease in the normal population in the Edinburgh Artery Study. Circulation, 87, 1915-1920.
27. Lowe, G.D.O., Fowkes, F.G.R., Koenig, W. & Mannucci, P.M. (eds) (1995) Fibrinogen and cardiovascular disease. European Heart Journal, 16, Supplement A.
28. Lowe, G.D.O., Rumley, A., Woodward, M., Morrison, C.E., Lane, D.A., Philippou, H. & Tunstall-Pedoe, H. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Study. I. Illustrative reference ranges by age, sex and hormone use. British Journal of Haematology, 97, 775-784.
29. Lowe, G.D.O., Wood, D.A., Douglas, J.T., Riemersma, R.A., MacIntyre, C.C.A., Takase, T., Tuddenham, E.G.D., Forbes. C.D., Elton, R.A. & Oliver, M.F. (1991) Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk-factors and angina. Thrombosis and Haemostasis, 65, 339-343.
30. Meade, T.W. (1994) Haemostatic function, arterial disease and the prevention of arterial thrombosis. Bailliere's Clinical Haematology, 7, 773-756.
31. Meade, T.W., Chakrabarti, R., Haines, A.P., North, W.R.S. & Stirling, Y. (1979) Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. British Medical Journal, i, 153-156.
32. Meade, T.W. Cooper, J., Miller, G.J., Howarth, D. & Stirling, Y. (1991) Antithrombin III and arterial disease. Lancet, 337, 850-851.
33. Meade, T.W., Cooper, J. A., Stirling, Y., Howarth, D.J., Ruddock, V. & Miller, G.J. (1994) Factor VIII, ABO blood group and the incidence of ischaemic heart disease. British Journal of Haematology, 88, 601-607.
34. Meade, T.W., Dyer, S., Howarth, D.J., Imeson, J.D. & Stirling, Y. (1990) Antithrombin III and procoagulant activity: sex differences and effects of the menopause. British Journal of Haematology, 74, 77-81.
35. Meade, T.W., Mellows, S., Brozovic, M., Miller, C.J., Chakrabarti, R.R., North, W.R.S., Haines, A.P., Stirling, Y., Imeson, J.D. & Thompson, S.G. (1986) Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet, ii, 533-537.
36. Meade, T.W., North, W.R.S., Chakrabarti, R., Haines, A.P. & Stirling, Y. (1977) Population-based distributions of haemostatic variables. British Medical Bulletin, 55, 283-288.
37. Meade, T.W., North, W.R.S., Chakrabarti, R., Stirling, Y., Haines, A.P. & Thompson, S.G. (1480) Haemostatic function and cardiovascular death: early results of a prospective study. Lancet, i, 1050-1054.
38. Miller, G.J. (1994) Lipoproteins in atherosclerosis. Baillière's Clinical Haematology, 7, 713-732.
39. Miller, G.J., Walter, S.J., Stirling, Y., Thompson, S.G., Esnouf, M.P. & Meade, T.W. (1985) Assay of factor VII activity by two techniques: evidence for increased conversion of VII to a VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. British Journal of Haematology, 59, 249-258.
40. Miller, G.J., Wilkes, H.C., Meade, T.W., Bauer, K.A., Barzegar, S. & Rosenberg, R.D. (1991) Haemostatic changes that constitute the hypercoagulable state. Lancet, 338, 1079.
41. Mitropoulos, K.A., Miller, G.J., Reeves, B.E.A., Wilkes, H.C. & Cruickshank, J.K. (1984) Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men. Atherosclerosis, 76, 203-208.
42. Office of Population Censuses and Surveys (1980) Classification of Occupations, 1980. HMSO, London.
43. Prineas, K.J., Crow, R.S. & Blackburn, H. (1982) The Minnesota Code Manual of Electrocardiographic Findings. John Wright, Bristol.
44. Rose, U., McCartney, P. & Reid, D.D. (1977) Self-administration of a questionnaire on chest pain and intermittent claudication. British Journal of Preventative and Social Medicine, 31, 42-8.
45. Rugman, F.P., Jenkins, J.A., Duguid, J.K., Bolton-Maggs, P. & Hay, C.R.M. (1994) Prothrombin fragment F1 + 2: correlations with cardiovascular risk factors. Blood Coagulation and Fibrinolysis, 5, 335-340.
46. Silveira, A., Karpe, F., Blomback, M., Steiner, G., Walldius, G. & Hamsten, A. (1994) Activation of coagulation factor VII during alimentary lipemia. Arteriosclerosis and Thrombosis, 14, 60-69.
47. Simpson, H.C.R., Meade, T.W., Stirling, Y., Mann, J.I., Chakrabarti, R. & Woolf, L. (1983) Hypertriglyceridaemia and hypercoagulability. Lancet, i, 786-789.
48. Small, M., Lowe, G.D.O., Douglas, J.T., Hutton, I., Lorimer, A.R. & Forbes, C.D. (1988) Thrombin and plasmin activity in coronary artery disease. British Heart Journal, 60, 201-204.
49. Smith, W.C.S., Tunstall-Pedoe, H., Crombie, J.K. & Tavendale, R. (1989) Concomitants of excess coronary deaths: major risk factor and life-style findings from 10,359 men and women in the Scottish heart health study. Scottish Medical Journal, 34, 550-555.
50. Tait, R.C., Walker, I.D., Islam, S.I.A.M., McCall, F., Conkie, J.A., Wight, M., Mitchell, R. & Davidson, J.F. (1993a) Protein C activity in healthy volunteers - influence of age, sex, smoking and oral contraceptives. Thrombosis and Haemostasis, 70, 281-284.
51. Tait, R.C., Walker, I.D., Islam, S.I.A.M., McCall, F., Conkie, J.A., Mitchell, R. & Davidson, J.F. (1993b) Influence of demographic factors on antithrombin III activity in a healthy population. British Journal of Haematology, 84, 478-480.
52. Vuilleumier, J.P. & Keck, E. (1989) Fluorometric assay of vitamin C in biological samples using a centrifugal analyser with fluorescence attachment. Journal of Micronutrient Analysis, 5, 25-34.
53. Woodward, M., Laurent, K. & Turtstall-Pedoe, H. (1995) An analysis of risk factors for prevalent coronary disease by using the proportional odds model. The Statistician, 44, 69-80.
54. Woodward, M., Tunstall-Pedoe, M., Smith, W.C.S. & Tavendale, R. (1991) Smoking characteristics and inhalation biochemistry in the Scottish population. Journal of Clinical Epidemiology, 44, 1405-1410.
55. World Health Organisation Principal Investigators (prepared by Tunstall-Pedoe, H.) (1988) The World Health Organisation MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. Journal of Clinical Epidemiology, 41, 105-113.